Core Viewpoint - The public fund industry is experiencing frequent adjustments in research and investment teams at the beginning of 2026, with 56 fund managers changing 153 funds as of January 18, indicating a normal talent flow in the industry [1][6]. Group 1: Fund Manager Changes - The adjustments are concentrated in leading institutions like Huaxia Fund and Harvest Fund, with many technology and manufacturing-themed products undergoing manager changes [1][6]. - A significant portion of the changes involves equity products, with 109 equity funds (71%) experiencing manager changes, primarily in mixed funds that track consumer and technology sectors [2][6]. Group 2: Performance of Affected Funds - Contrary to the stereotype that changes indicate poor performance, most affected funds are high-performing, with 142 out of 153 funds showing positive net value growth over the past year, and 14 funds exceeding a 50% increase [2][7]. - The average net value growth rate for the 60 funds that hired new managers is 22%, with 54 funds achieving positive growth [3][8]. Group 3: Reasons for Changes and Future Trends - The changes are seen as a strategy to enhance long-term management, allowing for better alignment with current market conditions and risk diversification through team collaboration [2][7]. - Experts suggest that hiring additional managers will become a key method for institutions to optimize their research and investment strategies, especially as market segments become more specialized [3][8]. - Looking ahead, adjustments in fund managers are expected to continue, particularly in equity products focused on technology and high-end manufacturing sectors [4][9].

Core Viewpoint - The public fund industry is experiencing frequent adjustments in research and investment teams at the beginning of 2026, with 56 fund managers changing across 153 funds as of January 18, indicating a normal talent flow in the industry [1][2]. Group 1: Fund Manager Changes - A total of 153 funds have undergone manager changes, with prominent institutions like Huaxia Fund and Harvest Fund seeing a significant number of changes, particularly in technology and manufacturing-themed products [1]. - The majority of the changes involve equity products, with 109 equity funds changing managers, accounting for 71% of the total, primarily in mixed funds that track consumer and technology sectors [1][2]. Group 2: Performance of Adjusted Funds - Contrary to the stereotype that changes indicate poor performance, 142 of the 153 adjusted funds have shown positive net value growth over the past year, with 14 funds exceeding a 50% increase [2]. - The average net value growth rate for the 60 funds that added managers is 22%, with 54 of these funds achieving positive growth [3]. Group 3: Reasons for Manager Changes - The adjustments are seen as a strategy to enhance long-term management, allowing for better alignment with current market trends and risk diversification through team collaboration [2][3]. - Experts suggest that the trend of adding managers will continue as institutions seek to optimize research and investment capabilities, particularly in specialized fields [3]. Group 4: Future Outlook - As the spring market unfolds, further adjustments in fund managers for equity products are anticipated, focusing on optimizing research configurations around technology and high-end manufacturing sectors [4].

Core Viewpoint - Fund manager Chen Qiming has managed two funds as of the end of Q2 2025, with the best-performing fund being Huafu Tianxin Flexible Allocation Mixed A (003152), which achieved a net value increase of 0.92% in the quarter [1]. Fund Performance Summary - Chen Qiming's managed funds include: - Huafu Dacai Flexible Allocation Mixed C (003153) with an annualized return of 5.68% and a Q2 increase of 0.70%, holding a major stock, Xuguang Electronics (600353.SH), at 7.23% of net value [2]. - Huafu Daxin Flexible Allocation Mixed A (003152) with an annualized return of 6.53% and a Q2 increase of 0.92%, also holding Xuguang Electronics at 7.23% of net value [2]. - During his tenure managing Huafu Value Growth Mixed A (410007), Chen achieved a cumulative return of 232.74% with an average annualized return of 11.77%, executing 96 stock adjustments with a success rate of 63.54% [2]. Stock Adjustment Cases - Notable stock adjustment cases managed by Chen Qiming include: - Boteng Co., Ltd. (300363) was bought in Q2 2018 and sold in Q3 2022, yielding an estimated return of 396.40% with a company performance growth of 1510.87% during the holding period [5]. - Yifeng Pharmacy (603939) was bought in Q2 2016 and sold in Q2 2019, yielding an estimated return of 96.12% with a company performance growth of 175.23% during the holding period [6]. - Beilu Pharmaceutical (300016) was bought in Q2 2015 and sold in Q1 2017, resulting in a loss of -59.25% despite a company performance growth of 264.70% during the holding period [7].